Various innovations after the past century have improved the world for many - but there’s still much more for universities to do.
Articles on Medical innovation
Displaying all articles
The key to supporting science innovation is funding and shaping it at its earliest stages, while innovative ventures are still housed within universities — and even before the ventures are founded.
Moderna co-founder Robert Langer developed the process that made COVID-19 vaccines possible. He spoke about his journey helping develop the science for various lifesaving treatments.
The development of COVID vaccines has already been explosive. There are more innovations on the way.
Medical innovations paired with innovative programs to get them to Black, Indigenous and Hispanic Americans can help close the health inequality gap.
Lessons from history make clear that the federal government can spur medical innovation in a crisis, including this pandemic. Providing certainty and clarity is critical.
The Canadian government must undertake regular analysis of the drug shortage problem, if we are ever to develop sustainable solutions.
Successfully separating conjoined twins is a complex operation that depends on how they are joined as well as the experience and skill of the surgical team.
Africa battles with a dearth of data and seems unable to scale up health innovations. If these can be systematically addressed, the continent can take great strides towards better health for all.
Drugs, new materials and even more creative uses: biodiversity is full of potential.
A parliamentary bill aims to assuage fears that innovative treatment will lead to doctors being sued – but the problem doesn’t exist.
Top contributors
-
Clinical Senior Research Associate, MRC Epidemiology Unit, University of Cambridge
-
Research fellow in Public Health, Africa University
-
Lecturer - Department of surgery Speciality: Plastic & Reconstructive Surgery, University of Nairobi
-
Associate Professor of Pharmacognosy, Addis Ababa University
-
Emeritus Professor, Macquarie University
-
Professor of Psychological Medicine, King's College London
-
Policy Analyst, Royal College of Psychiatrists
-
Institute Professor, Massachusetts Institute of Technology (MIT)
-
Professor of Health Policy, Columbia University
-
Dean of the Sol Price School of Public Policy; Distinguished Professor of Pharmacy, Public Policy, and Economics, University of Southern California
-
Assistant Professor of Gerontology and Edward L. Schneider Chair in Gerontology, University of Southern California
-
Professor Emerita in the Hannah Chair, History of Medicine, Queen's University, Ontario
-
Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
-
Associate Professor of Economics, University of California, San Diego
-
Van Dusen Professor of Innovation and Entrepreneurship , Simon Fraser University